Cargando…
Predictors of Health Utility in Relapsing–Remitting and Secondary-Progressive Multiple Sclerosis: Implications for Future Economic Models of Disease-Modifying Therapies
BACKGROUND: Decision-analytic models used in economic evaluations of disease-modifying therapies for relapsing–remitting multiple sclerosis (RRMS) have characterized disease progression and accrue quality-adjusted life-years from utility values based on the Expanded Disability Status Scale (EDSS), t...
Autores principales: | Hernandez, Luis, O’Donnell, Malinda, Postma, Maarten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867536/ https://www.ncbi.nlm.nih.gov/pubmed/32989685 http://dx.doi.org/10.1007/s40273-020-00964-w |
Ejemplares similares
-
Disease-modifying therapies in relapsing–remitting multiple sclerosis
por: González-Andrade, Fabricio, et al.
Publicado: (2010) -
Cost-utility analysis of disease-modifying drugs in relapsing-remitting multiple sclerosis in Iran
por: Imani, Ali, et al.
Publicado: (2012) -
Episodic Past, Future, and counterfactual thinking in Relapsing-Remitting Multiple sclerosis
por: Ayala, Oscar Daniel, et al.
Publicado: (2022) -
The Epidemiology, Treatment Patterns and Economic Burden of Different Phenotypes of Multiple Sclerosis in Italy: Relapsing-Remitting Multiple Sclerosis and Secondary Progressive Multiple Sclerosis
por: Perrone, Valentina, et al.
Publicado: (2022) -
Socio-economic status influences access to second-line disease modifying treatment in Relapsing Remitting Multiple Sclerosis patients
por: Calocer, Floriane, et al.
Publicado: (2018)